Publications by authors named "Chalermthai Aksilp"
Article Synopsis
- Nebulized budesonide is recognized as a suitable alternative to inhaled corticosteroids (ICS) for young children with asthma, but guidance on its use is limited.
- A group of 15 pediatric respiratory and allergy experts in Thailand created recommendations for nebulized budesonide after reviewing 24 relevant studies published between 1993 and 2020.
- The findings indicate that nebulized budesonide improves symptom control and reduces asthma exacerbations without severe side effects, positioning it as a preferred treatment option for children aged 5 years or younger alongside ICS.
Background: Acute asthmatic exacerbation in children causes economic burdens both directly and indirectly. The GINA guideline does mention the use of inhaled or oral corticosteroids in the treatment of asthmatic exacerbation, it provides little practical guidance on the use of nebulized corticosteroid.
Objective: To review and recommend the practical considerations in the use of nebulized corticosteroid in children with acute asthmatic exacerbation.